Unknown

Dataset Information

Proinflammatory cytokines driving cardiotoxicity in COVID-19.


ABSTRACT:

Aims

Cardiac involvement is common in patients hospitalized with COVID-19 and correlates with an adverse disease trajectory. While cardiac injury has been attributed to direct viral cytotoxicity, serum-induced cardiotoxicity secondary to serological hyperinflammation constitutes a potentially amenable mechanism that remains largely unexplored.

Methods and results

To investigate serological drivers of cardiotoxicity in COVID-19 we have established a robust bioassay that assessed the effects of serum from COVID-19 confirmed patients on human embryonic stem cell (hESC)-derived cardiomyocytes. We demonstrate that serum from COVID-19 positive patients significantly reduced cardiomyocyte viability independent of viral transduction, an effect that was also seen in non-COVID-19 acut

SUBMITTER: Colzani M 

PROVIDER: S-EPMC10936751 | biostudies-literature | 2024 Mar

REPOSITORIES: biostudies-literature